Nivel 3 · Studiu pe oameniStudiu observațional

Omega-3 fatty acids and Alzheimer's disease-related brain biomarkers in older adults enriched for preclinical Alzheimer's disease

Christifano DN, Kelly E, Sands SA, Honea RA, Morris JK, Burns JM, Taylor MK

Prostaglandins, leukotrienes, and essential fatty acids · 25 iulie 2026

REZUMATUL AUTORILOR

Background : Preclinical and limited human data suggest long-chain omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may be protective of brain volume and amyloid-beta (Aβ) accumulation, hallmarks of Alzheimer's disease (AD), which may be modulated by Apolipoprotein E ε4 (APOE4) carriage.

Methods : This cross-sectional study was conducted using baseline data from a clinical trial at the University of Kansas Medical Center that included cognitively normal older adults, enriched for preclinical AD. We investigated serum DHA+EPA's (% total triacylglycerol fatty acids) relationship with MRI-derived gray matter volume and PET-derived Aβ burden (Florbetapir F18) overall and by APOE4 carriage status.

Results : Among all participants (n = 104, 67.3% female, 69.2% preclinical AD, 44.2% APOE4), higher DHA+EPA was related to larger gray matter volume in a left precuneus/postcentral gyrus cluster, with similar relationships between APOE4 carriers and non-carriers. Higher DHA+EPA was also related to lower brain Aβ in the frontoparietal cortex, bilaterally. In APOE sensitivity analyses, higher DHA+EPA was related to lower global and AD-related regional brain Aβ among APOE4 carriers .

Conclusions : Higher DHA+EPA was associated with larger gray matter volume and lower Aβ in AD-susceptible regions, especially among APOE4 carriers. These findings are consistent with the hypothesis that omega-3 fatty acids influence brain volume and Aβ. Well-designed DHA+EPA supplementation RCTs are needed as DHA supplementation RCTs have inconsistently impacted brain volume and no RCTs investigating the impact of omega-3 on brain Aβ have been reported.

Trial registration : NCT02000583 (https://clinicaltrials.gov/study/NCT02000583?term=NCT02000583&viewType=Card&rank=1) registered on November 26, 2013.

Rezumat original, redat fără modificări. © Autorii, distribuit sub licență Creative Commons CC BY. Condițiile exacte sunt indicate în articolul original.

Informații științifice; nu înlocuiesc sfatul unui profesionist din domeniul sănătății. Prezența unui studiu în această bibliotecă nu constituie o mențiune privind produsele noastre.

← Toate studiile